2018: Briefing note on NIH proposed license to Gilead for CD-30 CAR T technology

Contact: Kim Treanor 202-332-2670; kim.treanor@keionline.org January 5, 2018 The National Institutes of Health (NIH) has proposed an exclusive license with Gilead for certain patent applications for inventions that target CD-30 proteins and CAR T technologies. The proposed license is to… Continue Reading

EB146: WHO proposes changes to the modalities of non-State actors’ engagement in WHO’s governing bodies

Currently, the participation of non-State actors in official relations with the World Health Organization (WHO) is regulated by the WHO’s Framework of Engagement with non-State actors (FENSA) which is “a privilege that the Executive Board may grant to nongovernmental organizations,… Continue Reading

CDIP 24: KEI provides comments on the Report on the International Conference on Intellectual Property (IP) and Development

On 20 May 2019, the World Intellectual Property Organization (WIPO) convened an International Conference on Intellectual Property (IP) and Development. On 19 November 2019, at the 24th session of WIPO’s Committee on Development and Intellectual Property (CDIP), Knowledge Ecology International… Continue Reading

Trilateral symposium: WTO Director General Roberto Azevêdo highlights the opportunities and challenges faced in providing access to CAR T

On Thursday, 31 October 2019, the World Trade Organization (WTO) hosted the eighth trilateral symposium jointly convened by the World Health Organization (WHO) and the World Intellectual Property Organization (WIPO). The theme of this year’s symposium was ” “Cutting-Edge Health… Continue Reading

WTO TRIPS Council (October 2019): Statement of South Africa on the Transparency of R&D Costs and Pricing of Medicines and Health Technology

On Friday, 18 October 2019, South Africa delivered the following statement at the WTO TRIPS Council on transparency of R&D Costs and Pricing of Medicines and Health Technology. Intellectual Property and the Public Interest: R&D Costs and Pricing of Medicines… Continue Reading

WTO TRIPS Council: Submission of South Africa on R&D Costs and Pricing of Medicines and Health Technologies

On Friday, 4 October 2019, the World Trade Organization (WTO) published a submission by the Republic of South Africa on “R&D Costs and Pricing of Medicines and Health Technologies” (IP/C/W/659). In this paper, South Africa requested the WTO TRIPS Council… Continue Reading